Literature DB >> 7024305

Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen-associated delta antigen.

O Crivelli, M Rizzetto, C Lavarini, A Smedile, J L Gerin.   

Abstract

A blocking enzyme-linked immunosorbent assay (ELISA) was developed for specific detection of antibody to the hepatitis B surface antigen-associated delta antigen. The sensitivity of ELISA was intermediate between that of previously described immunofluorescence and radioimmunological assays for anti-delta. Performance of ELISA was simple and required only ordinary and inexpensive laboratory equipment.

Mesh：

Substances：

Year:  1981        PMID： 7024305      PMCID： PMC271929          DOI： 10.1128/jcm.14.2.173-177.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay.

Authors:  L R Mathiesen; S M Feinstone; D C Wong; P Skinhoej; R H Purcell
Journal:  J Clin Microbiol       Date:  1978-02       Impact factor: 5.948

2.  Distribution of antibodies against the delta-antigen in HBsAg carriers detected by a simple immunofluorescence blocking test.

Authors:  O Crivelli; S Arico'; F Bonino; C Lavarini; M Rizzetto
Journal:  Acta Gastroenterol Belg       Date:  1978 May-Jun       Impact factor: 1.316

3.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

4.  Purification of naked intranuclear particles from human liver infected by hepatitis B virus.

Authors:  S Z Hirschman; M Gerber; E Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

5.  Radioimmunoassay for the detection of the core of the Dane particle and antibody to it.

Authors:  R H Purcell; J L Gerin; J B Almeida; P V Holland
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

6.  Antigenic conversion from HBcAg to HBeAg by degradation of hepatitis B core particles.

Authors:  H Ohori; M Yamaki; S Onodera; E Yamada; N Ishida
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

7.  A solid-phase enzyme immunoassay (EIA) for detection of HBeAg and anti-HBe.

Authors:  F Bonino; S Recchia; A Ponzetto; B Filippone; M Palla; A R Zanetti; P Ferroni
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

9.  Biophysical characterization of the adr subtype of hepatitis B antigen and preparation of anti-r sera in rabbits.

Authors:  J L Gerin; R M Faust; P V Holland
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

10.  Incidence and significance of antibodies to delta antigen in hepatitis B virus infection.

Authors:  M Rizzetto; J W Shih; D J Gocke; R H Purcell; G Verme; J L Gerin
Journal:  Lancet       Date:  1979-11-10       Impact factor: 79.321
View more
  10 in total

1.  Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies.

Authors:  A G Shattock; M C Morris
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

2.  New enzyme-linked immunosorbent assay for detection of antibodies against hepatitis delta virus using a hepatitis delta antigen derived from a Taiwanese clone and comparison to the Abbott radioimmunoassay.

Authors:  Yung-Bin Kuo; Mei Chao; Yi-Hsuan Lee; Chau-Ting Yeh; Err-Cheng Chan
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

3.  Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection.

Authors:  G Raimondo; G Longo; G Squadrito
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

4.  Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays.

Authors:  F Dubois; A Goudeau
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

5.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

Review 6.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Pathologic and ultrastructural changes of acute and chronic delta hepatitis in an experimentally infected chimpanzee.

Authors:  S Govindarajan; H A Fields; C D Humphrey; H S Margolis
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

8.  Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections.

Authors:  A G Shattock; F M Irwin; B M Morgan; I B Hillary; M G Kelly; J F Fielding; D A Kelly; D G Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

9.  Development of an enzyme immunoassay using recombinant expressed antigen to detect hepatitis delta virus antibodies.

Authors:  J Puig; H A Fields
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

Review 10.  Rapid and accurate viral diagnosis.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.